Related Experiment Video
Updated: May 12, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Comparison of injection dose force, accuracy and precision among three growth hormone injection devices
Anne-Marie Kappelgaard1, Niels-Åge Hansen
1Novo Nordisk A/S, Vandtaarnsvej 114 Søborg, DK 2860, Denmark. amk@novonordisk.com
Abstract:
Successful growth hormone (GH) therapy requires sustained treatment adherence, usually over long periods of time. However, adherence rates are often poor and this can lead to suboptimal clinical outcomes. Developments in GH injection devices aim to help improve adherence by making daily injections easier. Injection force is an important practical aspect for patients receiving daily GH injections, particularly for patients with small hands or reduced hand strength due to muscle weakness. Norditropin FlexPro (Novo Nordisk A/S, Bagsværd, Denmark) is an easy-to-use GH injection pen device, shown here to have reduced injection force, similar dose accuracy and greater dose precision compared with Norditropin NordiFlex (Novo Nordisk A/S) and Genotropin GoQuick (Pfizer Inc., NY, USA). Easier injections may enable patients to self-administer GH more readily and therefore potentially may help improve adherence and clinical outcome.
Related Concept Videos
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...

